shaoxuanong

Lemonade Insurance (LMND)

Long
NYSE:LMND   Lemonade, Inc.
First, let's talk about technicals. Tbh, not much support or resistance to be found since they just ipo recently. However, its a downward pennant, it might crack support go down to 48. Or bounce off and break resistance. I hope it breaks downwards so that i can buy and hold more. Why?

Fundamentals. This could possibly be the company that revolutionize one of the most distrusted industry on this planet - insurance. I love their business model and especially the CEO Daniel Schreiber himself. As a millennial myself, i absolutely abhor paper work from insurance even though i know its beneficial to have it. There's just this negative connotation tied with the current insurance market. "Scam" "Distrust" "Lies" and many more. It's not just in america but WORLDWIDE.

LMND is an innovative company that makes use of AI bots and data to generate a premium that is fairer and possibly cheaper. Claims are made and approved within seconds. And for those who understands about how AI works(i don't but i researched) the accuracy of the predictive grows exponentially as more data is being fed into the system.

Currrently LMND provides a few insurance options for clients but I'm pretty sure they will add in a few more as they grow.

Cost is going down.
Customer base are growing
A large majority of their customers are millenials. And that's their target customers.
Growing customer base.

Just a very brief summary about LMND. I love the concept and I would want to enter with a good position, averaging out bit by bit from now till january. This is a really long term hold. 10-20 years in my opinion. It could be a 10x company in that time.

Current global insurance market cap - $5.8t
As per current LMND price @ $58 a 10x stock growth would give it approximately $30b market cap.
That's just 0.5% of the current global insurance market.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.